Project Grant R43DK133083

Award Date 4/1/22
Completion Date 3/31/24
Dollars Obligated $505K
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98195, USA
Similar Awards
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $722,908 to fund a 4-year research project to investigate new ways to prevent and treat Hirschsprung disease-associated enterocolitis (HAEC), a life-threatening bowel inflammation in children with Hirschsprung disease. The research aims to analyze stool metabolites, gut...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $339,000.00 to New York University School of Medicine to conduct advanced genetic analyses and characterization of Hirschsprung disease (HSCR). The research aims to leverage whole genome sequencing data from 766 HSCR cases and their family members to improve detection of all variant types, including...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) aims to develop a novel diagnostic modality for quantifying upper airway obstruction (UAO) in patients with Robin sequence, a congenital craniofacial condition. The $250,931 award will fund the integration of dynamic computed tomography (4D-CT) imaging with computational fluid dynamics (CFD) modeling to create a patient-specific,...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) aims to develop a machine learning model that can more accurately diagnose clinically significant urinary tract obstruction in children with antenatal hydronephrosis, a common prenatal condition. The $155,011 award to the Cleveland Clinic Lerner College of Medicine will fund the development and...
This Project Grant award, provided by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" program (CFDA 93.286), aims to develop fast and robust methods for reconstructing coherent 3D fetal brain volumes from 2D MRI images and automatically generating accurate fetal brain biometrics. The $588,880 award, spanning from February 2025 to January 2029, will be led by the...
This Project Grant award from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) provides $741,747 to Harvard Medical School to validate and update two existing image-based diagnostic algorithms for remote detection of post-cesarean surgical site infections (SSIs) in diverse populations. The project aims to prospectively follow 6,000 women across sites in Rwanda, Ghana, and Mexico, collecting wound images and SSI...
This $630,847 Project Grant awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847) supports research conducted by Children's Mercy Hospital to investigate how the SIGIRR protein regulates intestinal barrier function and prevents necrotizing enterocolitis (NEC) in preterm infants. The key objectives are to determine how SIGIRR inhibits the TWIST1 transcription factor to maintain adherens and tight junctions in intestinal epithelial cells, and evaluate...
This Project Grant award from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) provides $757,089 to support research aimed at identifying novel genes and variants associated with congenital diaphragmatic hernia (CDH) and validating these discoveries in mouse models. The key objectives are to leverage genomic data from CDH patient cohorts to identify novel CDH-associated genes and variants, and then use a...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) aims to develop and validate an AI-assisted preimplantation kidney biopsy interpretation system. The $1,470,094 award to New York University School of Medicine will leverage a large dataset of over 10,000 biopsy images from multiple organ procurement organizations to construct a comprehensive...
This federal Project Grant award of $1,544,693, provided by the National Institute of Child Health and Human Development under CFDA 93.865 (Child Health and Human Development Extramural Research), aims to characterize gastrointestinal (GI) disorder trajectories and develop predictive models for risk profiles and treatment response among autistic sub-groups. The key products and services to be delivered under this 5-year award include: (1) qualitative analysis of narrative interviews with 25...

3D DIAGNOSIS OF HIRSCHSPRUNG DISEASE USING OPEN-TOP LIGHT-SHEET MICROSCOPY - ABSTRACT HIRSCHSPRUNG DISEASE IS A CONGENITAL DEFECT THAT AFFECTS AN ESTIMATED 1:5000 LIVEBORN INFANTS. IT IS CHARACTERIZED BY ABSENT GANGLION CELLS (NEURONS) IN THE DISTAL RECTUM AND A VARIABLE LENGTH OF CONTIGUOUS PROXIMAL BOWEL. THE DIAGNOSIS OF HIRSCHSPRUNG DISEASE RELIES UPON SUBJECTIVE PATHOLOGIST INTERPRETATION OF UP TO 100 TISSUE SECTIONS FROM SUCTION RECTAL BIOPSIES TO PROVE THE ABSENCE OF GANGLION CELLS AND THE PRESENCE OF HYPERTROPHIC NERVES. DUE TO THE LABOR-INTENSIVE AND TIME-CONSUMING NATURE OF THE CURRENT DIAGNOSTIC PROCESS, THERE IS A NEED TO MORE EFFICIENTLY AND COMPREHENSIVELY DIAGNOSE HIRSCHSPRUNG DISEASE. OUR TEAM HAS PIONEERED THE USE OF 3D OPEN-TOP LIGHT-SHEET (OTLS) MICROSCOPY, WHICH ENABLES RAPID, HIGH-THROUGHPUT IMAGING OF LARGE CLINICAL SAMPLES. IN COMBINATION WITH CUTTING-EDGE MACHINE LEARNING TECHNIQUES, WE HYPOTHESIZE THAT 3D OTLS MICROSCOPY CAN PROVIDE MORE ACCURATE AND CONSISTENT ASSESSMENT OF GANGLION CELLS AND HYPERTROPHIC NERVES IN SUCTION RECTAL BIOPSIES FROM PATIENTS WITH SUSPECTED HIRSCHSPRUNG DISEASE. WE WILL TEST THIS HYPOTHESIS BY DEVELOPING A MULTIPLEX STAINING PROTOCOL AND MACHINE LEARNING ANALYSIS PIPELINE, WHICH WILL BE PILOTED ON 100 RECTAL BIOPSY SPECIMENS FROM FRESH RESECTION SPECIMENS.

Posted 3/31/22, 12:00 AM